Discussion  by unknown
There has been much recent postulation as to factors that
influence postoperative outcomes at the hospital level. These
focus on processes of care, which may be associated with im-
proved outcome after surgery. Billingsley and colleagues21
have correlated improved outcomes after surgery for colon
cancer with the presence of solid organ transplantation teams,
as a proxy for patient care indices associated with improved
postoperative outcomes. Other processes of care studied and
correlated to improved outcomes include dedicated surgical
intensive care units managed by dedicated intensive care spe-
cialists,3,22 patient safety initiatives,23 and the use of multi-
disciplinary teams and standardized clinical care pathways
at high-volume centers, for example.24 We believe it is likely
that these hospital-level processes of care are more readily
available at high-volume centers, and as such, high-volume
status may serve as a proxy for them in large administrative
databases such as the NIS.
We show that, although there is a trend toward an inverse
relationship between volume and mortality, volume is not
sufficient for defining centers of excellence. Volume seems
to function as an imperfect surrogate for other variables,
which may better define centers of excellence, such as quality
of dedicated intensive care, postoperative monitoring, clini-
cal care pathways, and other processes of care.20,21,25,26 Ad-
ditional work is needed to identify those variables associated
with improved outcome after esophageal resection.
In addition, using a comparison of mortality rates and
goodness of fit of different volume thresholds, we were
unable to identify a clear, optimal volume threshold for
improved outcomes after esophagectomy for esophageal
cancer. We conclude that the use of volume thresholds alone
for determining centers of excellence does not appropriately
represent the variance in the data or necessarily guide appro-
priate decision making and should be avoided.
The authors thank Nita Ahuja, MD, for critical review of the
methods used in this study.
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Dr A. Pennathur (Pittsburgh, Penn). Dr Meguid, that was an
excellent presentation and I congratulate you on your efforts to de-
fine a cutoff volume. Dr Meguid and colleagues from the Johns
Hopkins Hospital have analyzed the outcomes of more than 3000
patients from more than 1000 hospitals derived from the NIS.
They analyzed the variable of esophagectomy volume with the pri-
mary outcome being in-hospital mortality. Their main objective
was to evaluate how valid hospital volume cutoffs are for defining
centers of excellence. The number of esophagectomies performed
in these hospitals ranged from a minimum of 1 to a maximum of
29. The median was somewhat lower, just 4 esophagectomies per
year. The overall mortality rate was 9.9%. After using esophagec-
tomy volume as a dichotomous variable initially, they went on to
perform a goodness-of-fit model, concluding that they were unable
to establish a cutoff value. They then concluded that volume cutoffs
cannot be used to determine centers of excellence and further work
is needed to investigate this.
Several large single-institution series have been published with
remarkably low mortality rates, including your institution; ours,gery c January 2009
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Swhere in a series of 222 consecutive esophagectomies had a mortal-
ity rate of 1.4%; and excellent results from other larger series, such
as those from Drs Orringer, Altorki, and Swanson, to name a few.
However, this relationship between esophagectomy volume and
outcome is complex, with several factors playing a role. These fac-
tors include the surgeon volume, specialty training of the surgeon,
comorbidities in the patient, and provision for critical care services.
Adding to these factors is the case mix seen at a particular hospital,
which may contribute. For example, the referral pattern of a private
hospital may be much different than that of an inner-city hospital.
So my first question is, given the complexities of the volume–
outcome relationship, do you think it is possible that you can reduce
this to a single number across all hospitals in the United States with-
out taking into consideration other important factors, such as sur-
geon volume, expertise, and patient population?
Dr Meguid. The impetus for our study was the curiosity to see
how the seemingly arbitrary cutoff of 13 fared against other volume
cutoffs. We expected to see a dramatic difference in mortality rates,
for instance, but were, quite frankly, shocked by the apparent lack
of the difference between choosing 13 and any other volume cutoff.
As you point out, the relationship between individual and hospi-
tal operative volume and the processes of care and outcome is very
complex. Unfortunately, it’s difficult to study the effect of different
processes of care because of lack of information available in these
multi-institutional databases. Using a patient-focused database,
such as the Society of Thoracic Surgeons’ database, would be ideal;
however, at the present time data are lacking for such analysis, and
unfortunately, use of all of our own single-institution databases
lends to bias.
Dr Pennathur. The second question is, did you first conduct an
analysis of all the data in this particular cohort of patients to estab-
lish a functional relationship between mortality and volume in this
cohort before dichotomizing these patients?
Dr Meguid. Yes, sir. Before dichotomizing the data at the differ-
ent cutoff points, we did examine the unadjusted relationship between
volume and in-hospital death and found this to be an inversely linear
relationship. When we adjusted for age, patient gender, patient race,
and patient comorbidities, we also saw that that persisted.
Dr Pennathur. The next thing is, using mortality as an outcome
variable, how do you do a risk-adjusted mortality rate? For example,
from your article, when the volume was greater than 10, the mortal-
ity rate was 5.3%. However, when the volume was greater than or
equal to 29, the mortality was actually higher; it was 8.6%. Is this
because sicker patients are going to high-volume hospitals? Perhaps
a more useful reporting might be a risk-adjusted mortality rate.
Dr Meguid. Yes, I fully agree with you. In dichotomizing a con-
tinuous variable, one is combining all of the values below and
above that cutoff into 2 values. As a result, the lowest mortality
rate was observed at a volume cutoff of 10, but when the volume
cutoff was raised, a lower mortality rate was not observed. Again,
that’s one of the prime complications of using a dichotomous
model for continuous variables.
Dr Pennathur. Along the same lines, are you going to attempt to
take other variables into consideration, such as nutritional status of
patients, which has been shown to be important; socioeconomic
status; specialty training of the surgeon, which has been show to
be important; and elective versus emergent procedures, all of which
are going to have an impact on mortality?The Journal of Thoracic andDr Meguid. Yes, I fully agree with you regarding the impor-
tance of these factors. Unfortunately, because of the administrative
nature of the NIS database, one is unable to account for many ger-
mane factors, such as cancer staging, preoperative nutritional sta-
tus, and neoadjuvant or postoperative chemo- and radiotherapy.
One can control for gender, some patient demographics, which
aren’t necessarily specific to operative mortality, the Charlson
Comorbidity Index, and some hospital demographics. This is,
again, a big limitation with these administrative datasets.
Dr M. Jaklitsch (Boston, Massachusetts). I’m just deeply con-
cerned that your highest output hospital was 29 cases per year, and
we all know of excellent academic centers of excellence that do
more than 29 per year. So either they are not in the database, the
most sterling outcomes are not in this database, or they are in this
database but with incomplete data. I don’t know how you can
draw conclusions from this if either 1 of those 2 cases is true.
Dr Meguid. Dr Jaklitsch, that’s an excellent point. In fact, when
we looked at a similar example using pancreatic resections, we found
a similarly small range, and that motivated us at Johns Hopkins to look
into why we don’t find institutions with 100 resections per year.
Subsequently, in this nationally representative sample, we find that
a lot of the hospitals are lower-volume hospitals and we don’t see
a lot of the larger academic centers included every year in this
database. So that is, again, a limitation specific to the NIS database.
Dr Jaklitsch. Can I ask, how many cases a year do you do at
Hopkins?
Dr Meguid. I’m not sure, I believe it’s in the 50s. Dr Yang?
Dr Yang. It’s about 75.
Dr Jaklitsch. So Hopkins’ data, for instance, is not in this?
Dr Meguid. It’s not in the NIS, no, sir.
Dr T. Grodzki (Szczecin, Poland). Did you make a differentiation
between hospital volume and surgeon volume? Because it’s not the
same. And did you analyze the mortality reasons? Were they due
to technical failure or the imperfections in postoperative care?
Dr Meguid. Those are very good points. We chose to use hos-
pital volume, although we could have examined physician volume.
We chose to use hospital volume because that is what has been used
in other models, including the Leapfrog Group, and we wanted to
analyze these cutoffs in particular. Unfortunately, we can’t tease
out what postoperative complications occur in these patients be-
cause of the limitations of this dataset.
Dr D. Wood (Seattle, Wash). I have the same concern that Dr
Jaklitsch expressed, but also a concern about how you have repre-
sented the conclusion. It would seem that volume is an important
surrogate for mortality outcomes, yet you have found that there is
not a good cutoff for volume. That does not mean that volume
isn’t important, which it sounds like in the conclusion. Rather, vol-
ume is very important; we just cannot create a cutoff to define an
‘‘adequate’’ volume. So I think that it is very important to refine
the message, because policymakers, like Leapfrog, need a clear
message that volume is important in terms of quality of outcomes,
unless you think that this research disputes that premise.
Dr Meguid. Dr Wood, you have made an excellent point. I don’t
want to misrepresent our findings. Our findings are that a specific
cutoff is an inappropriate way to determine centers of excellence.
However, in this example, increased volume is correlated with
decreased complications and mortality, and that should not be
overlooked.Cardiovascular Surgery c Volume 137, Number 1 29
